Table 1. Serum angiogenic and inflammatory factors according to clinicopathological features in colorectal cancer patients.
|
CRP (μg ml–1)
|
VEGF-A (pg ml–1)
|
Ang-2 (pg ml–1)
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total N | Mean | Standard deviation | P-value | Mean | Standard deviation | P-value | Mean | Standard deviation | P-value | |
| Gender (N total=344) | ||||||||||
| Female | 171 | 5.44 | 3.05 | <0.001a | 432 | 375 | 0.084a | 3050 | 1501 | 0.001a |
| Male | 173 | 4.02 | 3.07 | 364 | 345 | 2536 | 1311 | |||
| Age groups (N total=344) | ||||||||||
| 31–50 | 13 | 3.52 | 2.42 | 275 | 210 | 2591 | 2413 | |||
| 51–60 | 28 | 4.53 | 3.14 | 0.030b | 430 | 417 | 0.732b | 2061 | 854 | 0.004b |
| 61–70 | 102 | 4.12 | 3.05 | 0.026c | 398 | 370 | 0.425c | 2600 | 1306 | 0.022c |
| 71–80 | 146 | 4.99 | 3.12 | 409 | 343 | 2928 | 1482 | |||
| 81–91 | 55 | 5.55 | 3.28 | 379 | 394 | 3206 | 1287 | |||
| AJCC (N total=343) | ||||||||||
| I | 69 | 3.20 | 2.57 | 367 | 332 | 2637 | 1501 | |||
| IIA | 115 | 5.00 | 3.14 | 323 | 263 | 2674 | 1301 | |||
| IIB | 29 | 5.50 | 3.48 | <0.001b | 495 | 450 | 0.021b | 2972 | 1189 | 0.258b |
| IIIA | 9 | 4.45 | 3.42 | <0.001c | 309 | 181 | 0.066c | 2649 | 1344 | 0.093c |
| IIIB | 71 | 4.85 | 3.07 | 441 | 430 | 2766 | 1357 | |||
| IIIC | 36 | 5.05 | 3.16 | 537 | 402 | 3331 | 1970 | |||
| IV | 14 | 7.38 | 2.08 | 459 | 469 | 3057 | 1207 | |||
| T stage (N total=342) | ||||||||||
| T1 | 28 | 3.18 | 2.67 | 246 | 267 | 2369 | 1064 | |||
| T2 | 59 | 3.71 | 2.77 | <0.001b | 440 | 359 | 0.064b | 2776 | 1583 | 0.007b |
| T3 | 182 | 4.92 | 3.08 | <0.001c | 388 | 362 | 0.025c | 2664 | 1278 | 0.007c |
| T4 | 73 | 5.64 | 3.38 | 447 | 383 | 3276 | 1672 | |||
| N stage (N total=337) | ||||||||||
| N0 | 214 | 4.54 | 3.17 | 361 | 320 | 2709 | 1357 | |||
| N1 | 79 | 4.86 | 3.01 | 0.181b | 432 | 439 | 0.061b | 2789 | 1325 | 0.069b |
| N2 | 44 | 5.48 | 3.14 | 0.07c | 488 | 387 | 0.034c | 3267 | 1872 | 0.021c |
| Grade (N total=245) | ||||||||||
| 1 | 8 | 2.69 | 1.89 | 0.001b | 566 | 412 | 0.094b | 2552 | 865 | 0.087b |
| 2 | 176 | 4.46 | 3.03 | 0.004c | 376 | 358 | 0.335c | 2719 | 1412 | 0.245c |
| 3 | 58 | 5.91 | 3.33 | 467 | 403 | 3194 | 1716 | |||
| Lymph/vascular invasion (N total=337) | ||||||||||
| No | 236 | 4.49 | 3.01 | 0.102a | 354 | 301 | 0.016a | 2685 | 1268 | <0.001a |
| Yes | 101 | 5.14 | 3.42 | 469 | 431 | 3053 | 1754 | |||
| Perineural invasion (N total=159) | ||||||||||
| No | 135 | 4.50 | 3.29 | 0.331a | 461 | 366 | 0.487a | 2877 | 1522 | 0.805a |
| Yes | 17 | 5.32 | 3.14 | 396 | 330 | 2977 | 1869 | |||
| Necrosis (N total=180) | ||||||||||
| No | 142 | 4.34 | 3.01 | 0.002a | 357 | 354 | 0.559a | 2536 | 1101 | 0.012a |
| Yes | 38 | 6.12 | 3.35 | 395 | 351 | 3084 | 1463 | |||
| Lymphocytic infiltrate (N total=267) | ||||||||||
| No | 92 | 4.69 | 3.45 | 428 | 343 | 2738 | 1365 | |||
| 1 | 112 | 5.02 | 2.99 | 0.270b | 360 | 321 | 0.192b | 2728 | 1340 | 0.589b |
| 2 | 49 | 4.21 | 3.02 | 0.153c | 327 | 263 | 0.126c | 2610 | 1411 | 0.176c |
| 3 | 14 | 3.64 | 2.49 | 296 | 300 | 2246 | 701 | |||
Abbreviations: AJCC=American Joint Committee on Cancer; Ang-2=angiopoietin-2; ANOVA=analysis of variance; CRP=C-reactive protein; VEGF-A=vascular endothelial growth factor-A.
Independent-samples t-test.
One-way ANOVA.
Test for linear trend.